Title: Paul McCormac: Innovator in Oligonucleotide Technology
Introduction
Paul McCormac is a notable inventor based in Great Britain, recognized for his contributions to the field of oligonucleotide technology. Despite having no patents to his name, his work has significantly impacted the development of processes related to oligonucleotides.
Latest Patents
Paul McCormac's latest patents include two significant processes. The first is titled "Process For Preparing Oligonucleotides," which details a method for assembling an oligonucleotide attached to a solid support. This process involves the polymerization of a monomer that contains a protected hydroxypolyC2-4 alkyleneoxy chain. The second patent, "Process For Purifying Oligonucleotide Synthons," outlines a purification method for oligonucleotide synthons using nanofiltration to enhance the ratio of oligonucleotide synthons to lower molecular weight impurities.
Career Highlights
Throughout his career, Paul McCormac has worked with prominent companies in the biotechnology sector, including Avecia Biotechnology, Inc. and Nitto Denko Avecia, Inc. His experience in these organizations has allowed him to develop and refine his innovative processes.
Collaborations
Paul has collaborated with notable individuals in his field, including Stephen Hargreaves and Andrew Timothy Boam. These partnerships have contributed to the advancement of his work and the broader field of oligonucleotide technology.
Conclusion
In summary, Paul McCormac is an influential figure in the realm of oligonucleotide technology, with a focus on innovative processes that enhance the preparation and purification of oligonucleotides. His contributions, although not patented, reflect a commitment to advancing scientific knowledge and technology.